AimsTo investigate the pharmacokinetics of unbound (ultrafilterable) and total plasma platinum using a population approach and to identify patient characteristics that may influence the disposition of the drug. MethodsPharmacokinetic and demographic data were collected from adult patients treated with 30-min daily infusions of cisplatin for various malignancies. Unbound and total platinum concentration-time data were analysed using a nonlinear mixed effects model. ResultsData from 43 patients were available for analysis. A linear two-compar tment model best described total and unbound platinum plasma concentration-time data. The mean population estimates for total and unbound drug were, respectively, 0.68 and 35.5 l h -1 for clearance and 21.1 and 23.4 l for central distribution volume ( V 1 ). Unbound clearance (CL) was dependent on body surface area (BSA) and creatinine clearance, and V 1 was dependent on BSA. The elimination rate constant for plasmabound platinum (modelled as metabolite formation) was 0.014 h -1 . The pharmacokinetic parameter, f m / V m , a measure of the clearance of unbound platinum due to irreversible plasma binding, was related to serum protein concentration and to the inverse of dose per m 2 . The covariate modelling of CL, V 1 and f m / V m improved the intersubject variabilities associated with these parameters. The final pharmacokinetic models were validated using 200 bootstrap samples from the original datasets. ConclusionsThe results support the conventional dose adjustment of cisplatin based on B SA. They also support the need for a dose reduction in case of renal insufficiency.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.